Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Survodutide Research# Key trials include the obesity Phase 2 (Lancet Diabetes & Endocrinology, 2024, 18.7% weight loss), MASH Phase 2 (NEJM, 2024, 62% MASH resolution), SYNCHRONIZE-1/2 (Phase 3, obesity, fully enrolled), and LIVERAGE (Phase 3, MASH, ongoing)
It has centuries of use in traditional Chinese and Ayurvedic medicine, and it is by far the most studied supplement in the GLP-1 conversation
A RECENT cohort study has highlighted the potential of tirzepatide to significantly improve clinical outcomes in patients with Type 2 diabetes, particularly in comparison to the commonly used glucagon-like peptide 1 receptor agonists (GLP-1 RAs)
The GIP component is what makes tirzepatide unique compared to older medications like semaglutide
HOW IT WORKS GLP-1 medications are typically administered through injections prescribed by a licensed medical practitioner
